DEC 27, 2016 7:41 PM PST

Super-Enhancers Implicated in Autoimmune Disease

WRITTEN BY: Kara Marker

Regulatory T cells (Tregs) step in to mute the immune system after it has mounted a response against whatever foreign invader is tormenting the body. An immune attack is necessary to keep the body protected from invaders, but at a certain point Tregs ensure that the immune system does not go overboard and hurt healthy human cells, causing autoimmune disease.

Source: EpiBeat

The current study from the Immunology Frontier Research Center (IFReC) at Osaka University in Japan thusly focused on the origin of Tregs, of the precursor cells that are destined to become the specialized T cells that prevent autoimmune reactions.

They found that Treg development, which occurs in the thymus, is controlled by the establishment of super-enhancers, regulators of gene expression that appear to also be involved in Treg development.  “Super-enhancers appeared to be a pre-requisite for Treg cell development, so we sought molecules controlling super-enhancers,” explained IFReC professor Shimon Sakaguchi.

They found that the molecular mechanism behind Treg malfunction, which causes autoimmune diseases, was a protein called Satb1, which the observed as a regulator of the super-enhancers essential for Treg cell development.

Satb1 levels are inherently highest just before Tregs develop, and there is a sudden reduction right after they eventually develop. This connection is due to the bond between Satb1 and the super-enhancers responsible for Treg development, researchers found, but Satb1 is not bound to the Tregs themselves.

“Satb1 appears to be necessary for the differentiation of Treg cells but not for the maintenance of Treg cells,” explained first author Dr. Yohko Kitagawa.

During their study, mutant mice lacking Satb1 showed impaired Treg development and signs of autoimmune disease. Additionally, Treg progenitor cells exhibited inferior super enhancer activity, leading to a reduction in expression of vital genes for Treg development.

Ultimately, Sakaguchi, Kitagawa, and the rest of the research team concluded that a lack of ample Satb1-dependent super-enhancers could be causing autoimmune diseases and allergies in some people, a result that leaves room for future research into Satb1 as a target for treating these conditions.

The current study was recently published in the journal Nature Immunology.

Sources: Osaka University, Immunology Frontier Research CenterNature Genetics

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 19, 2021
Immunology
Insights Into the Interplay Between COVID and the Nasal Microbiome
AUG 19, 2021
Insights Into the Interplay Between COVID and the Nasal Microbiome
There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while oth ...
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 09, 2021
Drug Discovery & Development
Can vaccines help prevent and treat opioid addiction?
SEP 09, 2021
Can vaccines help prevent and treat opioid addiction?
According to the United States Centers for Disease Control (CDC), 136 people die from an opioid overdose every ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
Loading Comments...